The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Systematic Review and Meta-analysis of Clinical and Economic Outcomes from the Implementation of Hospital-Based Antimicrobial Stewardship Programs
Open accessAbstract
The implementation of antimicrobial stewardship programs (ASPs) is a promising strategy to help address the problem of antimicrobial resistance. We sought to determine the efficacy of ASPs and their effect on clinical and economic parameters. We searched PubMed, EMBASE, and Google Scholar looking for studies on the efficacy of ASPs in hospitals. Based on 26 studies (extracted from 24,917 citations) with pre- and postimplementation periods from 6 months to 3 years, the pooled percentage change of total antimicrobial consumption after the implementation of ASPs was −19.1% (95% confidence interval [CI] = −30.1 to −7.5), and the use of restricted antimicrobial agents decreased by −26.6% (95% CI = −52.3 to −0.8). Interestingly, in intensive care units, the decrease in antimicrobial consumption was −39.5% (95% CI = −72.5 to −6.4). The use of broad-spectrum antibiotics (−18.5% [95% CI = −32 to −5.0] for carbapenems and −14.7% [95% CI = −27.7 to −1.7] for glycopeptides), the overall antimicrobial cost (−33.9% [95% CI = −42.0 to −25.9]), and the hospital length of stay (−8.9% [95% CI = −12.8 to −5]) decreased. Among hospital pathogens, the implementation of ASPs was associated with a decrease in infections due to methicillin-resistant Staphylococcus aureus (risk difference [RD] = −0.017 [95% CI = −0.029 to −0.005]), imipenem-resistant Pseudomonas aeruginosa (RD = −0.079 [95% CI = −0.114 to −0.040]), and extended-spectrum beta-lactamase Klebsiella spp. (RD = −0.104 [95% CI = −0.153 to −0.055]). Notably, these improvements were not associated with adverse outcomes, since the all-cause, infection-related 30-day mortality and infection rates were not significantly different after implementation of an ASP (RD = −0.001 [95% CI = −0.009 to 0.006], RD = −0.005 [95% CI = −0.016 to 0.007], and RD = −0.045% [95% CI = −0.241 to 0.150], respectively). Hospital ASPs result in significant decreases in antimicrobial consumption and cost, and the benefit is higher in the critical care setting. Infections due to specific antimicrobial-resistant pathogens and the overall hospital length of stay are improved as well. Future studies should focus on the sustainability of these outcomes and evaluate potential beneficial long-term effects of ASPs in mortality and infection rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Wan, X., Wang, W., Liu, J., & Tong, T. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-135 · Cited by 11,735
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins, W. C., Paterson, D. L., Fishman, N. O., Carpenter, C. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510393 · Cited by 3,362
Metaprop: a Stata command to perform meta-analysis of binomial data
Nyaga, V. N., Arbyn, M., & Aerts, M. (2014) · Archives of Public Health · doi:10.1186/2049-3258-72-39 · Cited by 2,139
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Brown, E., Charani, E., Fenelon, L., Gould, I. M., Holmes, A., Ramsay, C. R., Wiffen, P. J., & Wilcox, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub3 · Cited by 1,864
Undue reliance on I 2 in assessing heterogeneity may mislead
Rücker, G., Schwarzer, G., Carpenter, J. R., & Schumacher, M. (2008) · BMC Medical Research Methodology · doi:10.1186/1471-2288-8-79 · Cited by 1,287
Fazel, S., Khosla, V., Doll, H., & Geddes, J. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050225 · Cited by 1,033
Schuts, E. C., Hulscher, M. E. J. L., Mouton, J. W., Verduin, C. M., Stuart, J. W. T. C., Overdiek, H. W. P. M., van der Linden, P. D., Natsch, S., Hertogh, C. M. P. M., Wolfs, T. F. W., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00065-7 · Cited by 758
Ndiaye, C., Mena, M., Alemany, L., Arbyn, M., Castellsagué, X., Laporte, L., Bosch, F. X., de Sanjosé, S., & Trottier, H. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70471-1 · Cited by 722
Antimicrobial Stewardship Programs in Health Care Systems
MacDougall, C., & Polk, R. E. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.638-656.2005 · Cited by 705
Fridkin, S. K., Steward, C. D., Edwards, J. R., Pryor, E. R., McGowan, Jr., Archibald, L. K., Gaynes, R. P., & Tenover, F. C. (1999) · Clinical Infectious Diseases · doi:10.1086/520193 · Cited by 486
How to obtain the P value from a confidence interval
Altman, D. G., & Bland, J. M. (2011) · BMJ · doi:10.1136/bmj.d2304 · Cited by 462
How to obtain the confidence interval from a P value
Altman, D. G., & Bland, J. M. (2011) · BMJ · doi:10.1136/bmj.d2090 · Cited by 402
Vital signs: improving antibiotic use among hospitalized patients.
Fridkin, S. K., Baggs, J. M., Fagan, R. P., Magill, S. S., Pollack, L. A., Malpiedi, P. J., Slayton, R. B., Khader, K., Rubin, M. A., Jones, M., et al. (2014) · PubMed Central · Cited by 401
The rising problem of antimicrobial resistance in the intensive care unit
Brusselaers, N., Vogelaers, D., & Blot, S. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-47 · Cited by 350
Bantar, C., Sartori, B., Vesco, E., Heft, C., Saul, M., Salamone, F., & Oliva, M. E. (2003) · Clinical Infectious Diseases · doi:10.1086/375818 · Cited by 253
Antibiotic Resistance—Squeezing the Balloon?
Burke, J. P. (1998) · JAMA · doi:10.1001/jama.280.14.1270 · Cited by 237
Zacharioudakis, I. M., Zervou, F. N., Pliakos, E. E., Ziakas, P. D., & Mylonakis, E. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.22 · Cited by 230
Self-citationGlance, L. G. (2011) · Archives of Surgery · doi:10.1001/archsurg.2011.41 · Cited by 218
Antimicrobial Stewardship Programs in Inpatient Hospital Settings: A Systematic Review
Wagner, B. L., FILICE, G. A., Drekonja, D. M., Greer, N. L., MacDonald, R. H., Rutks, I. R., Butler, M. E., & Wilt, T. J. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/599172 · Cited by 189
Gerding, D. N. (2004) · Clinical Infectious Diseases · doi:10.1086/382084 · Cited by 175
Effectiveness of Education and an Antibiotic-Control Program in a Tertiary Care Hospital in Thailand
Apisarnthanarak, A., Danchaivijitr, S., Khawcharoenporn, T., Limsrivilai, J., Warachan, B., Bailey, T. C., & Fraser, V. J. (2006) · Clinical Infectious Diseases · doi:10.1086/500325 · Cited by 169
Rüttimann, S., Keck, B., Hartmeier, C., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/380964 · Cited by 149
Factors Influencing the Length of Hospital Stay of Patients with Heart Failure
Wright, S. P., Verouhis, D., Gamble, G. D., Swedberg, K. B., Sharpe, N., & Doughty, R. N. (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(02)00201-5 · Cited by 138
Hutchinson, J. M., Patrick, D. M., Marra, F., Ng, H., Bowie, W., Heule, L., Muscat, M., & Monnet, D. L. (2004) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2004/389092 · Cited by 126
Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram
Cook, P., Catrou, P. G., Christie, J. D., Young, P. D., & Polk, R. E. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh163 · Cited by 121
Cisneros, J. M., Neth, O., Gil-Navarro, M. V., Lepe, J. A., Jiménez-Parrilla, F., Cordero, E., Rodríguez-Hernández, M. J., Amaya‐Villar, R., Cano, J., Gutiérrez-Pizarraya, A., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12191 · Cited by 117
Stoking the antibiotic pipeline
Morel, C. M., & Mossialos, E. A. (2010) · BMJ · doi:10.1136/bmj.c2115 · Cited by 117
Agwu, A. L., Lee, C. K. K., Jain, S. K., Murray, K. L., Topolski, J., Miller, R. E., Townsend, T. R., & Lehmann, C. U. (2008) · Clinical Infectious Diseases · doi:10.1086/591133 · Cited by 109
Boyles, T. H., Whitelaw, A. C., Bamford, C., Moodley, V. M., Bonorchis, K., Morris, V., Rawoot, N., Naicker, V., Lusakiewicz, I., Black, J. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079747 · Cited by 106
Antimicrobial resistance: No action today, no cure tomorrow
Sharma, A. (2011) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.81774 · Cited by 101
Niwa, T., Shinoda, Y., Suzuki, A., Ohmori, T., Yasuda, M., Ohta, H., Fukao, A., Kitaichi, K., Matsuura, K., Sugiyama, T., et al. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02999.x · Cited by 95
Yeo, C. L., Chan, D. S.-G., Earnest, A., Wu, T. S., Yeoh, S. F., Lim, R., Jureen, R., Fisher, D. A., & Hsu, L. Y. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1351-6 · Cited by 79
Effective antibiotic-resistance control strategies
Cunha, B. A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04527-x · Cited by 71
Prescribing trends before and after implementation of an antimicrobial stewardship program
Cairns, K. A., Jenney, A. W. J., Abbott, I. J., Skinner, M. J., Doyle, J., Dooley, M. J., & Cheng, A. C. (2013) · The Medical Journal of Australia · doi:10.5694/mja12.11683 · Cited by 63
Amer, M. R., Akhras, N. S., Mahmood, W., & Al‐Jazairi, A. S. (2013) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2013.547 · Cited by 59
Kim, Y. C., Kim, M. H., Song, J. E., Ahn, J. Y., Oh, D. H., Kweon, O. M., Lee, D.-S., Kim, S. B., Kim, H.-W., Jeong, S. J., et al. (2013) · American Journal of Infection Control · doi:10.1016/j.ajic.2012.12.018 · Cited by 59
Meyer, E., Buttler, J., Schneider, C., Strehl, E., Schroeren-Boersch, B., Gastmeier, P., Rüden, H., Zentner, J., Daschner, F. D., & Schwab, F. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm088 · Cited by 55
Borde, J., Kaier, K., Steib–Bauert, M., Vach, W., Geibel, A., Busch, H.-J., Bertz, H., Hug, M. J., de With, K., & Kern, W. V. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-201 · Cited by 51
Borde, J., Kern, W. V., Hug, M. J., Steib–Bauert, M., de With, K., Busch, H.-J., & Kaier, K. (2014) · Emergency Medicine Journal · doi:10.1136/emermed-2014-204067 · Cited by 50
Pető, Z., Benkő, R., Matúz, M., Csüllög, E., Molnar, A., & Hajdú, E. (2008) · Infection · doi:10.1007/s15010-008-7377-8 · Cited by 49
Borde, J., Litterst, S., Ruhnke, M., Feik, R., Hübner, J., de With, K., Kaier, K., & Kern, W. V. (2014) · Infection · doi:10.1007/s15010-014-0693-2 · Cited by 42
Ng, C., Wu, T. C., Chan, W. M. J., Leung, Y. S. W., Li, C. K. P., Tsang, D. N. C., & Leung, G. M. (2008) · BMJ Quality & Safety · doi:10.1136/qshc.2007.023267 · Cited by 41
Strategies to control antibiotic resistance
Cunha, B. A. (2002) · Seminars in Respiratory Infections · doi:10.1053/srin.2002.34692 · Cited by 38
Nitsch-Osuch, A. S., Kurpas, D., Kuchar, E. P., Życińska, K., Zielonka, T. M., & Wardyn, K. A. (2014) · Advances in experimental medicine and biology · doi:10.1007/5584_2014_32 · Cited by 17
Nitsch-Osuch, A. S., Kuchar, E. P., Życińska, K., Gyrczuk, E., Miśkiewicz, K., & Korzeniewski, K. (2015) · Advances in experimental medicine and biology · doi:10.1007/5584_2015_124 · Cited by 9
Cited by
Baur, D., Gladstone, B. P., Burkert, F., Carrara, E., Foschi, F., Döbele, S., & Tacconelli, E. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30325-0 · Cited by 850
Stemming the Superbug Tide: Just A Few Dollars More
OECD (2018) · OECD Health Policy Studies · doi:10.1787/9789264307599-en · Cited by 748
The challenge of antimicrobial resistance: What economics can contribute
Roope, L. S. J., Smith, R. D., Pouwels, K. B., Buchanan, J., Abel, L., Eibich, P., Butler, C. C., Tan, P. S., Walker, A. S., Robotham, J. V., et al. (2019) · Science · doi:10.1126/science.aau4679 · Cited by 575
Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review
Nathwani, D., Varghese, D., Stephens, J., Ansari, W., Martin, S., & Charbonneau, C. (2019) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0471-0 · Cited by 457
On behalf of the Fracture-Related Infection (FRI) group, Metsemakers, W.-J., Morgenstern, M., Senneville, E., Borens, O., Govaert, G. A. M., Onsea, J., Depypere, M., Richards, R. G., Trampuz, A., et al. (2020) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/s00402-019-03287-4 · Cited by 313
Metadata
- Authors
- Karanika, S., Paudel, S., Grigoras, C., Kalbasi, A., & Mylonakis, E.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2016-08
- Volume
- 60
- Issue
- 8
- Pages
- 4840-4852
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2416627116
- Cited by
- 402
- References
- 53
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.